These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8654129)

  • 21. Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid.
    Li N; Su Q; Tan F; Zhang J
    Int J Pharm; 2010 Mar; 387(1-2):167-71. PubMed ID: 20025951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study.
    Akl EM
    J Dermatolog Treat; 2022 Jun; 33(4):2008-2013. PubMed ID: 33823725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
    Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
    J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream.
    Baliña LM; Graupe K
    Int J Dermatol; 1991 Dec; 30(12):893-5. PubMed ID: 1816137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.
    Moncada B; Castillo-Martínez C; Arenas E; León-Bejarano F; Ramírez-Elías MG; González FJ
    Skin Res Technol; 2016 May; 22(2):170-3. PubMed ID: 26179661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
    Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
    Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical delivery systems for azelaic acid: effect of the suspended drug in microemulsion.
    Pattarino F; Carlotti ME; Gasco MR
    Pharmazie; 1994 Jan; 49(1):72-3. PubMed ID: 8140138
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of a cream based on 20% azelaic acid in the treatment of melasma].
    Rigoni C; Toffolo P; Serri R; Caputo R
    G Ital Dermatol Venereol; 1989; 124(1-2):I-VI. PubMed ID: 2767714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
    Worret WI; Fluhr JW
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
    Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
    J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosacea: could topical azelaic acid and oral tetracyclines modify videocapillaroscopic pattern?
    Ganzetti G; Giuliodori K; Campanati A; Offidani A
    Skinmed; 2014; 12(2):128-30. PubMed ID: 24933858
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of reticulate acropigmentation of Kitamura with azelaic acid. An immunohistochemical and electron microscopic study.
    Kameyama K; Morita M; Sugaya K; Nishiyama S; Hearing VJ
    J Am Acad Dermatol; 1992 May; 26(5 Pt 2):817-20. PubMed ID: 1613143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of melasma: a review of clinical trials.
    Gupta AK; Gover MD; Nouri K; Taylor S
    J Am Acad Dermatol; 2006 Dec; 55(6):1048-65. PubMed ID: 17097400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer and upcoming therapies for melasma.
    Sarkar R; Chugh S; Garg VK
    Indian J Dermatol Venereol Leprol; 2012; 78(4):417-28. PubMed ID: 22772611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical agents used in the management of hyperpigmentation.
    Halder RM; Richards GM
    Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
    Sofen B; Prado G; Emer J
    Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial.
    Iraji F; Faghihi G; Siadat AH; Enshaieh S; Shahmoradi Z; Joia A; Soleimani F
    J Drugs Dermatol; 2010 Aug; 9(8):964-8. PubMed ID: 20684146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The stepwise approach to the treatment of melasma.
    Perez MI
    Cutis; 2005 Apr; 75(4):217-22. PubMed ID: 15916218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.